Chimeric Antigen Receptor (CAR) T-cell Therapy Clinical Trials Funding Policy

Ontario Health (Cancer Care Ontario) provides funding to support eligible academic CAR T-cell therapy clinical trials in Ontario to:

• increase access to care
• drive Canadian innovation and advancement in technology
• potentially improve the long-term financial sustainability of therapies

Funding supports costs associated with the delivery of clinical care for eligible CAR T-cell therapy clinical trials. The CAR T-cell Therapy Clinical Trials Funding Policy outlines funding eligibility criteria and describes the application and evaluation process.

Download the CAR T-cell Therapy Clinical Trials Funding Policy.

Request a New Application

1. Before requesting an application form, review the CAR T-cell Therapy Clinical Trials Funding Policy to ensure the trial meets funding eligibility criteria and to understand the details of the application and evaluation process.
2. Request a copy of the CAR T-cell Therapy Clinical Trials Application Form by email.

Email Us

To request an application form, or to ask questions about the CAR T-cell Therapy Clinical Trials Funding Policy or funding application process, email the Specialized Services Oversight Program.

Please do not send us personal health information – including health care number, diagnosis, treatment plans – or any other personal information or attachments.